GSK1521498 free base is a potent and selective µ-opioid receptor antagonist. It is utilized in preclinical research for investigating potential therapeutic interventions in conditions such as obesity, alcohol use disorder, and substance addiction, employing both in vitro binding assays and in vivo behavioral models.
